Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.57p
   
  • Change Today:
      0.010p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 778,494
  • Market Cap: £12.84m
  • RiskGrade: 328

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
94.1% below the market average94.1% below the market average94.1% below the market average94.1% below the market average94.1% below the market average
80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
87.12% below the market average87.12% below the market average87.12% below the market average87.12% below the market average87.12% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average
Price Chg 3m
71.8% below the market average71.8% below the market average71.8% below the market average71.8% below the market average71.8% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
16.99% below the market average16.99% below the market average16.99% below the market average16.99% below the market average16.99% below the market average
24.44% below the sector average24.44% below the sector average24.44% below the sector average24.44% below the sector average24.44% below the sector average
Momentum 20
16.85% above the market average16.85% above the market average16.85% above the market average16.85% above the market average16.85% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
48.93% below the market average48.93% below the market average48.93% below the market average48.93% below the market average48.93% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
64% below the market average64% below the market average64% below the market average64% below the market average64% below the market average
10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
81.15% below the market average81.15% below the market average81.15% below the market average81.15% below the market average81.15% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Cash
83.7% below the market average83.7% below the market average83.7% below the market average83.7% below the market average83.7% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.57p
Change Today 0.010p
% Change 0.39 %
52 Week High 5.90
52 Week Low 1.09
Volume 778,494
Shares Issued 499.72m
Market Cap £12.84m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.19% below the market average73.19% below the market average73.19% below the market average73.19% below the market average73.19% below the market average
36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average
Price Trend
81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
15:33 61,799 @ 2.40p
15:33 61,799 @ 2.40p
15:26 196,293 @ 2.39p
15:01 60,000 @ 2.35p
14:06 19,940 @ 2.46p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page